Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and lidocaine infusion in thyroidectomy
ChiCTR1900025761Phase 4Not yet recruiting
- Sponsor
- Renmin Hospital, Hubei University of Medicine
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine and lidocaine in thyroid disease (4 arms), sponsored by Renmin Hospital, Hubei University of Medicine. Primary endpoint: cytokines. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
dexmedetomidinelidocaine
03
Conditions
thyroid disease
Beyond the preview
Go deeper on ChiCTR1900025761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025761.